Loading market dashboard
Asarina Pharma AB (publ)
ASAP.STHealthcareSTOSE
Business DescriptionOpen for the full company profile when you need deeper context.
Business Description
Open for the full company profile when you need deeper context.
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
Check out other names from the same Biotechnology industry as ASAP.ST.